Human [Ala31] IGF-I

$190.00

Human [Ala31] Insulin-like Growth Factor-I ([Ala31] IGF-I) is a modified analogue of human IGF-I featuring an alanine substitution at position 31 in place of tyrosine. It exhibits reduced binding affinity for the type 1 IGF receptor and insulin receptor while maintaining normal interaction with acid-stripped human serum binding proteins. This reagent is intended for research use only and is not suitable for diagnostic or therapeutic applications.

Human [Ala31]insulin-like Growth Factor-I ([Ala31]IGF-I) is an analogue of human IGF-I which has an Alanine substitution in place of Tyrosine at position 31 of the human IGF-I sequence. [Ala31]IGF-I has normal binding to acid-stripped human serum binding proteins but has reduced binding to the type 1 IGF receptor and to the insulin receptor compared to IGF-I. It has a slightly higher affinity for the type 1 IGF receptor than [Leu24]IGF-I and [Leu60]IGF-I and is able to elicit a weak biological response through this receptor. It is a useful analogue for studying the balance of effects of IGF-I through the type 1 receptor and IGF binding proteins.

This product is manufactured in Australia by GroPep Bioreagents.

Size 100 µg
Source Species Recombinant
Expression System Ecoli
Storage 2-8°C
Alternative Names Human [Ala31] Insulin-like Growth Factor-I ([Ala31] IGF-I)

Product Citations